434 related articles for article (PubMed ID: 16410124)
1. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
[TBL] [Abstract][Full Text] [Related]
3. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
[TBL] [Abstract][Full Text] [Related]
7. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
8. Captopril reduces the severity of bowel damage in a neonatal rat model of necrotizing enterocolitis.
Zani A; Eaton S; Leon FF; Malerba A; Hall NJ; De Coppi P; Smith VV; Pierro A
J Pediatr Surg; 2008 Feb; 43(2):308-14. PubMed ID: 18280280
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
[TBL] [Abstract][Full Text] [Related]
10. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
[TBL] [Abstract][Full Text] [Related]
12. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats.
Guven A; Gundogdu G; Vurucu S; Uysal B; Oztas E; Ozturk H; Korkmaz A
J Pediatr Surg; 2009 Sep; 44(9):1730-5. PubMed ID: 19735816
[TBL] [Abstract][Full Text] [Related]
13. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
Radulescu A; Zorko NA; Yu X; Besner GE
Pediatr Res; 2009 Apr; 65(4):437-42. PubMed ID: 19127210
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model.
Guven A; Gundogdu G; Uysal B; Cermik H; Kul M; Demirbag S; Ozturk H; Oter S
J Pediatr Surg; 2009 Mar; 44(3):534-40. PubMed ID: 19302854
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
[TBL] [Abstract][Full Text] [Related]
16. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
Nair RR; Warner BB; Warner BW
Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.
Radulescu A; Zhang HY; Yu X; Olson JK; Darbyshire AK; Chen Y; Besner GE
J Pediatr Surg; 2010 Oct; 45(10):1933-9. PubMed ID: 20920709
[TBL] [Abstract][Full Text] [Related]
18. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
Wei J; Besner GE
J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.
Yu X; Radulescu A; Zorko N; Besner GE
Gastroenterology; 2009 Jul; 137(1):221-30. PubMed ID: 19361505
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.
Radulescu A; Yu X; Orvets ND; Chen Y; Zhang HY; Besner GE
J Pediatr Surg; 2010 Apr; 45(4):729-34. PubMed ID: 20385279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
